Application of rhizoma corydalis-radix angelicae extract in preparation of medicine for treating rhinitis
The invention discloses application of a rhizoma corydalis-radix angelicae extract in preparation of a medicine for treating rhinitis, and belongs to the field of preparation of anti-rhinitis medicines. The rhizoma corydalis-radix angelicae extract has a definite treatment effect on improving rhinitis symptoms, and the effect is superior to that of dexamethasone serving as a clinical common medicine. The rhinitis treatment effect of the medicine is evaluated by comparing the nose scratching frequency, the sneezing frequency and the nasal cavity lavage fluid IgE release amount, it is determined that the rhizoma corydalis-radix angelicae extract formed when the mass ratio of the vinegar rhizoma corydalis to the radix angelicae is 1: 1 can improve the allergic rhinitis symptom, and the rhizoma corydalis-radix angelicae extract can be used for preparing the rhinitis medicine. The medicine composition with the ratio of 1: 1 has a better effect than the medicine composition with vinegar-processed rhizoma corydalis and radix angelicae which are independently used or the medicine composition with the ratio of 2: 1, and the synergistic effect is achieved; the toxicity is lower than that of single use, and the toxicity reducing effect is achieved..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 02. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HE LANGCHONG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-02, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
CN117323364 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA001124005 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA001124005 | ||
| 003 | DE-627 | ||
| 005 | 20240329160048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA001124005 | ||
| 035 | |a (EPA)CN117323364 | ||
| 035 | |a (EPA)89292829 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HE LANGCHONG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of rhizoma corydalis-radix angelicae extract in preparation of medicine for treating rhinitis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-02, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 | ||
| 520 | |a The invention discloses application of a rhizoma corydalis-radix angelicae extract in preparation of a medicine for treating rhinitis, and belongs to the field of preparation of anti-rhinitis medicines. The rhizoma corydalis-radix angelicae extract has a definite treatment effect on improving rhinitis symptoms, and the effect is superior to that of dexamethasone serving as a clinical common medicine. The rhinitis treatment effect of the medicine is evaluated by comparing the nose scratching frequency, the sneezing frequency and the nasal cavity lavage fluid IgE release amount, it is determined that the rhizoma corydalis-radix angelicae extract formed when the mass ratio of the vinegar rhizoma corydalis to the radix angelicae is 1: 1 can improve the allergic rhinitis symptom, and the rhizoma corydalis-radix angelicae extract can be used for preparing the rhinitis medicine. The medicine composition with the ratio of 1: 1 has a better effect than the medicine composition with vinegar-processed rhizoma corydalis and radix angelicae which are independently used or the medicine composition with the ratio of 2: 1, and the synergistic effect is achieved; the toxicity is lower than that of single use, and the toxicity reducing effect is achieved. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHANG TAO |4 aut | |
| 700 | 0 | |a WANG NAN |4 aut | |
| 700 | 0 | |a LIU YUN |4 aut | |
| 700 | 0 | |a ZHANG YONGJING |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 02. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:02 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89292829/publication/CN117323364A1?q=CN117323364 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 02 |c 01 | ||